A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus.
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
A blind, randomised, prospective, bilateral study to investigate the efficacy of riboflavin/ultraviolet
A corneal collagen cross-linkage to halt the progression of keratoconus.